Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathophysiology of bleeding in surgery.

M Marietta1, L Facchini, P Pedrazzi

  • 1Department of Oncology and Hematology, Section Hematology, University of Modena and Reggio Emilia, Modena, Italy. marietta@mail.unimo.it

Transplantation Proceedings
|May 2, 2006
PubMed
Summary

Surgical bleeding is a major complication, with severe cases increasing mortality risk. Recombinant activated factor VII (rFVIIa) shows promise in managing massive bleeding unresponsive to standard treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of vaccinations in patients with multiple sclerosis: a systematic review.

European review for medical and pharmacological sciences·2024
Same author

Inspiratory Effort and Respiratory Mechanics in Patients with Acute Exacerbation of Idiopathic Pulmonary fibrosis: A Preliminary Matched Control Study.

Pulmonology·2022
Same author

Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: A multicentre regional cohort study.

Pulmonology·2022
Same author

Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria.

Annals of hematology·2018
Same author

'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

Bone marrow transplantation·2017
Same author

Thiotepa-based high-dose therapy for autologous stem cell transplantation in lymphoma: a retrospective study from the EBMT.

Bone marrow transplantation·2015

Area of Science:

  • Surgical Complications
  • Hemostasis
  • Pharmacology

Background:

  • Bleeding is a significant surgical complication, with mortality rates escalating in vascular and major surgeries.
  • Excessive blood loss correlates with increased mortality, morbidity, and prolonged intensive care unit stays.
  • Technical factors cause most bleeding, but coagulopathies can also contribute.

Purpose of the Study:

  • To review the efficacy of recombinant activated factor VII (rFVIIa) in managing surgical bleeding.
  • To assess rFVIIa's potential advantage over conventional therapies for massive hemorrhage.

Main Methods:

  • Review of existing literature and case reports on rFVIIa use in surgical bleeding.
  • Analysis of anecdotal evidence regarding rFVIIa's hemostatic effects.

Related Experiment Videos

Main Results:

  • Standard treatments for surgical bleeding include source control and hemostatic agents.
  • Recombinant activated factor VII (rFVIIa) has been reported effective for massive bleeding unresponsive to conventional therapy.
  • Anecdotal reports suggest rFVIIa may offer a hemostatic advantage in complex cases.

Conclusions:

  • While most evidence is anecdotal, the reported cases suggest rFVIIa's potential in managing severe surgical bleeding.
  • Further investigation may be warranted to confirm rFVIIa's role in specific bleeding scenarios.